Upload

Loading icon Loading...

This video is unavailable.

Personal Genome Computing: Breakthroughs, Risks and Opportunities

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like ChurchillClub's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike ChurchillClub's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add ChurchillClub's video to your playlist.

Uploaded on Feb 2, 2009

"Technology breakthroughs are making DNA sequencing faster and cheaper than ever. In its top ten list of 2008 scientific breakthroughs that broke through with the potential for lasting impact, Science magazine included technology that has blown the doors off genome sequencing. In Nature magazines list of the top news stories of 2008, "Personal genomics goes mainstream" came in second. With the cost of DNA sequencing plummeting, the emergence of "molecular sequencing" platforms has forever changed the field of genetics.

A new paradigm appears on the horizon. Personal genome information will be used not just for health maintenance, disease diagnosis, and treatment, but will also be the foundation for lifestyle applications from shopping for food, to buying cosmetics, to assessing ones environment and making choices about fabrics, places - even friends.

This panel of Silicon Valley players and innovators of new business models examines the dynamic business and investment opportunities as well as the risks, global competition, regulatory and legal challenges, new individual contributor roles, and leading alliances emerging from Silicon Valley and beyond.

Silicon Valley changed the world as the driving force in the development of computers and the internet. Could we play a similar role in advancing a genome-based economy?". Panelists:

•Linda Avey, Founder, 23andMe.
•David Medina, HP Chief Technologist, Worldwide Health & Life Sciences
•Karoly Nikolich., Dievini Hopp Biotech Holding, CEO of Amnestix
•Andras Pellionisz, founder, International Hologenomics Society and HolGenTech
•Dietrich Stephan, founder, Navigenics, founder of Amnestix

Moderator:
•Phyllis Whiteley, Mohr-Davidow Ventures

Sponsor/Organizer:
•Gutenberg Communications: Suzanne Matick, Principal, Los Gatos Office

Churchill Club
Thursday January 22, 2009, Palo Alto, CA
www.churchillclub.org

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to